Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' reply

被引：0
|
作者：
Bettinger, D. [1 ]
Knueppel, E. [1 ]
Euringer, W. [2 ]
Spangenberg, H. C. [1 ]
Roessle, M. [1 ,3 ]
Thimme, R. [1 ]
Schultheiss, M. [1 ]
机构：
[1] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany
[2] Univ Hosp Freiburg, Dept Diagnost & Intervent Radiol, Freiburg, Germany
[3] PraxisZentrum Gastroenterol & Endokrinol, Freiburg, Germany
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2015年 / 41卷 / 02期
关键词：
D O I：
10.1111/apt.13038
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [1] Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma
    Rowe, I. A.
    Tripathi, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 230 - 230
  • [2] Editorial: screening for hepatocellular carcinoma in NAFLD cirrhosis-towards abbreviated MRI alternative in patients with obesity? Authors' reply
    Huang, Daniel Q.
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (09) : 1212 - 1213
  • [3] TIPSS and reversal of sarcopenia, and TIPSS is a promising therapy for sarcopenia in cirrhosis-Authors' reply
    Artru, Florent
    Labreuche, Julien
    Louvet, Alexandre
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (01) : 211 - 212
  • [4] Editorial: neutrophil dysfunction in patients with cirrhosis - authors' reply
    Taylor, N. J.
    Ma, Y.
    Shawcross, D. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (08) : 987 - 987
  • [5] TIPSS improves muscle mass indices in patients with cirrhosis and severe portal hypertension - authors' reply
    Artru, Florent
    Labreuche, Julien
    Louvet, Alexandre
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (01) : 199 - 200
  • [6] Editorial: frequency of surveillance and survival in hepatocellular carcinoma-authors' reply
    Kim, H. Y.
    Lee, J. -H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) : 229 - 230
  • [7] Editorial: redrawing the boundaries for surgical intervention in hepatocellular carcinoma-authors' reply
    Wang, Yan-Yan
    Zhong, Jian-Hong
    Mao, Yi-Lei
    Li, Le-Qun
    Xing, Bao-Cai
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (05) : 616 - 617
  • [8] Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Authors' reply
    Chang, De-Hua
    Xiao, Yu-Dong
    Yao, Tong
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (01) : 175 - 176
  • [9] Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply
    Danta, Mark
    Tan, Regina Zi Hwei
    Lockart, Ian
    Abdel Shaheed, Christina
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (06) : 852 - 853
  • [10] Commentary: predicting survival in hepatocellular carcinoma patients - authors' reply
    Crooks, C.
    Card, T.
    West, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (07) : 681 - 682
12345